Melenda Jeter

3.3k total citations
50 papers, 1.6k citations indexed

About

Melenda Jeter is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Oncology. According to data from OpenAlex, Melenda Jeter has authored 50 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pulmonary and Respiratory Medicine, 17 papers in Radiation and 15 papers in Oncology. Recurrent topics in Melenda Jeter's work include Lung Cancer Diagnosis and Treatment (27 papers), Advanced Radiotherapy Techniques (17 papers) and Lung Cancer Treatments and Mutations (14 papers). Melenda Jeter is often cited by papers focused on Lung Cancer Diagnosis and Treatment (27 papers), Advanced Radiotherapy Techniques (17 papers) and Lung Cancer Treatments and Mutations (14 papers). Melenda Jeter collaborates with scholars based in United States, China and Japan. Melenda Jeter's co-authors include Zhongxing Liao, Joe Y. Chang, Ritsuko Komaki, Mary Frances McAleer, James D. Cox, Thomas Guerrero, Peter Balter, Reza J. Mehran, Michael S. O’Reilly and Stephen M. Hahn and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Melenda Jeter

48 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melenda Jeter United States 21 1.2k 612 481 415 357 50 1.6k
Kayoko Tsujino Japan 21 1.3k 1.1× 570 0.9× 733 1.5× 323 0.8× 452 1.3× 72 1.9k
Kae Okuma Japan 22 604 0.5× 253 0.4× 277 0.6× 491 1.2× 310 0.9× 91 1.3k
Takuyo Kozuka Japan 17 1.1k 0.9× 595 1.0× 484 1.0× 291 0.7× 272 0.8× 67 1.6k
Alberto Testori Italy 20 792 0.7× 210 0.3× 298 0.6× 300 0.7× 364 1.0× 93 1.4k
Shervin M. Shirvani United States 17 917 0.8× 500 0.8× 436 0.9× 154 0.4× 318 0.9× 56 1.3k
Christopher D. Koprowski United States 13 717 0.6× 316 0.5× 309 0.6× 136 0.3× 354 1.0× 31 1.1k
Yoshiki Takada Japan 17 1.7k 1.4× 519 0.8× 443 0.9× 157 0.4× 878 2.5× 36 2.0k
Marta Moreno Spain 17 887 0.7× 477 0.8× 490 1.0× 308 0.7× 449 1.3× 58 1.4k
Karl-Axel Johansson Sweden 21 1.6k 1.3× 1.3k 2.1× 886 1.8× 282 0.7× 339 0.9× 44 2.2k
Ramzi Abdulrahman United States 15 1.6k 1.4× 1.3k 2.2× 750 1.6× 276 0.7× 274 0.8× 39 2.1k

Countries citing papers authored by Melenda Jeter

Since Specialization
Citations

This map shows the geographic impact of Melenda Jeter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melenda Jeter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melenda Jeter more than expected).

Fields of papers citing papers by Melenda Jeter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melenda Jeter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melenda Jeter. The network helps show where Melenda Jeter may publish in the future.

Co-authorship network of co-authors of Melenda Jeter

This figure shows the co-authorship network connecting the top 25 collaborators of Melenda Jeter. A scholar is included among the top collaborators of Melenda Jeter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melenda Jeter. Melenda Jeter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Welsh, James W., John V. Heymach, Dawei Chen, et al.. (2019). Phase I Trial of Pembrolizumab and Radiation Therapy after Induction Chemotherapy for Extensive-Stage Small Cell Lung Cancer. Journal of Thoracic Oncology. 15(2). 266–273. 57 indexed citations
2.
Elhammali, Adnan, Pierre Blanchard, Zhongxing Liao, et al.. (2019). Clinical outcomes after intensity-modulated proton therapy with concurrent chemotherapy for inoperable non-small cell lung cancer. Radiotherapy and Oncology. 136. 136–142. 20 indexed citations
3.
Gomez, Daniel R., Wei Xiong, Ritsuko Komaki, et al.. (2018). Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 101(3). 558–563. 52 indexed citations
4.
Kim, Catherine S. & Melenda Jeter. (2017). Radiation Therapy For Early Stage Non-Small Cell Lung Cancer. StatPearls. 5 indexed citations
5.
Chang, Joe Y., Wencheng Zhang, Ritsuko Komaki, et al.. (2017). Long-term outcome of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer. Radiotherapy and Oncology. 122(2). 274–280. 28 indexed citations
6.
Xu, Cai, Zhongxing Liao, Joe Y. Chang, et al.. (2017). Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional Analysis. International Journal of Radiation Oncology*Biology*Physics. 99(3). 667–676. 71 indexed citations
7.
Sun, Bing, Eric D. Brooks, Ritsuko Komaki, et al.. (2017). Long-Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non–Small Cell Lung Cancer: A Phase II Clinical Trial. Journal of Thoracic Oncology. 12(6). 983–992. 52 indexed citations
8.
9.
10.
Kono, Miho, Pamela K. Allen, Steven H. Lin, et al.. (2017). Incidence of Second Malignancy after Successful Treatment of Limited-Stage Small–Cell Lung Cancer and Its Effects on Survival. Journal of Thoracic Oncology. 12(11). 1696–1703. 12 indexed citations
11.
Kono, Miho, Pamela K. Allen, Steven H. Lin, et al.. (2016). Incidence of and Survival Outcomes After Metachronous Second Primary Malignancy After the Treatment of Limited-Stage Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 96(2). E430–E430. 1 indexed citations
12.
Zhang, Zhen, Chen Yuan, Yanzhi Chen, et al.. (2009). Outcomes with Esophageal Cancer Radiation Therapy. Journal of Thoracic Oncology. 4(7). 880–888. 3 indexed citations
13.
Smith, Grace L., Benjamin D. Smith, Thomas A. Buchholz, et al.. (2009). Patterns of Care and Locoregional Treatment Outcomes in Older Esophageal Cancer Patients: The SEER-Medicare Cohort. International Journal of Radiation Oncology*Biology*Physics. 74(2). 482–489. 43 indexed citations
14.
Starkschall, George, Keith R. Britton, Mary Frances McAleer, et al.. (2009). Potential Dosimetric Benefits of Four-Dimensional Radiation Treatment Planning. International Journal of Radiation Oncology*Biology*Physics. 73(5). 1560–1565. 37 indexed citations
15.
McGovern, Susan L., Zhongxing Liao, M. Kara Bucci, et al.. (2009). Is sex associated with the outcome of patients treated with radiation for nonsmall cell lung cancer?. Cancer. 115(14). 3233–3242. 16 indexed citations
16.
Chang, Joe Y., Peter Balter, Lei Dong, et al.. (2008). Stereotactic Body Radiation Therapy in Centrally and Superiorly Located Stage I or Isolated Recurrent Non–Small-Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 72(4). 967–971. 202 indexed citations
17.
Shioyama, Yoshiyuki, Si Young Jang, H. Helen Liu, et al.. (2007). Preserving Functional Lung Using Perfusion Imaging and Intensity-Modulated Radiation Therapy for Advanced-Stage Non–Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 68(5). 1349–1358. 86 indexed citations
18.
Rice, David C., W. Roy Smythe, Zhongxing Liao, et al.. (2007). Dose-Dependent Pulmonary Toxicity After Postoperative Intensity-Modulated Radiotherapy for Malignant Pleural Mesothelioma. International Journal of Radiation Oncology*Biology*Physics. 69(2). 350–357. 112 indexed citations
19.
Zhang, Zhen, Zhongxing Liao, Jing Jin, et al.. (2005). Dose–response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 61(3). 656–664. 100 indexed citations
20.
Cox, James D., Craig Stevens, Jack A. Roth, et al.. (2003). Equivalent outcome of patients with clinical Stage IIIA non–small-cell lung cancer treated with concurrent chemoradiation compared with induction chemotherapy followed by surgical resection. International Journal of Radiation Oncology*Biology*Physics. 58(1). 204–212. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kayoko Tsujino Breakdown of academic impact, for papers by Kae Okuma Breakdown of academic impact, for papers by Takuyo Kozuka Breakdown of academic impact, for papers by Alberto Testori Breakdown of academic impact, for papers by Shervin M. Shirvani Breakdown of academic impact, for papers by Christopher D. Koprowski Breakdown of academic impact, for papers by Yoshiki Takada Breakdown of academic impact, for papers by Marta Moreno Breakdown of academic impact, for papers by Karl-Axel Johansson Breakdown of academic impact, for papers by Ramzi Abdulrahman
Rankless by CCL
2026